Fedro Peccatori
www.mendeley.com
0000-0001-8227-8740
178 papers found
Refreshing results…
Mammaglobin expression in Leukapheresis products is a predictive marker of poor prognosis in women with high-risk breast cancer
Chemotherapy during pregnancy: what is really safe?
Prognostic Value of Troponin I in Cardiac Risk Stratification of Cancer Patients Undergoing High-Dose Chemotherapy
ChlVPP/ABVVP, a first line 'hybrid' combination chemotherapy for advanced Hodgkin's lymphoma: A retrospective analysis
Phase IB and pharmacological study of the novel taxane BMS-184476 in combination with doxorubicin
Efficacy of Vinblastine, Bleomycin, Methotrexate (VBM) Combination Chemotherapy with Involved Field Radiotherapy in Early Stage (I-IIA) Hodgkin Disease Patients
Erratum: ACOD, a modified CHOP regimen for elderly patients with aggressive non-Hodgkin's lymphoma (Leukemia & Lymphoma (2003) vol. 44 (5) (801-806))
ACOD, a Modified CHOP Regimen for Elderly Patients with Aggressive Non-Hodgkin's Lymphoma
Thalidomide in multiple myeloma, myelodysplastic syndromes and histiocytosis. Analysis of clinical results and of surrogate angiogenesis markers
Erratum: Thalidomide in multiple myeloma, myelodysplastic syndromes and histiocytosis. Analysis of clinical results and of surrogate angiogenesis markers (Annals of Oncology (2001) vol. 12 (7) (987-990))
Clinical and pharmacological phase I study with accelerated titration design of a daily times five schedule of BBR3464, a novel cationic triplatinum complex
Human myeloid and lymphoid malignancies in the non-obese diabetic/severe combined immunodeficiency mouse model: Frequency of apoptotic cells in solid tumors and efficiency and speed of engraftment correlate with vascular endothelial growth factor production
Evaluation of acute toxicities associated with autologous peripheral blood progenitor cell reinfusion in patients undergoing high-dose chemotherapy
Angiogenic growth factors and endostatin in non-Hodgkin's lymphoma [3] (multiple letters)
Angiogenic growth factors and endostatin in non-Hodgkin's lymphoma
Totally implantable central venous access ports for high-dose chemotherapy administration and autologous stem cell transplantation: Analysis of overall and septic complications in 68 cases using a single type of device
Expression of CD3-ζ on T-cells in primary cervical carcinoma and in metastasis-positive and -negative pelvic lymph nodes
ChlVPP/ABV-VP16 Hybrid Regimen for Advanced Hodgkin's Disease: a Study in 36 Patients
Friedreich's ataxia and intrathecal chemotherapy in a patient with lymphoblastic lymphoma [1]
Hematopoietic progenitor cell collection and neoplastic cell contamination in breast cancer patients receiving chemotherapy plus granulocyte-colony stimulating factor (G-CSF) or G-CSF alone for mobilization
Missing publications? Search for publications with a matching author name.